Coronavirus Drug Discovery: Antiviral Agents from Natural Products and Nanotechnological Applications

Coronavirus Drug Discovery, Volume 2: Antiviral Agents from Natural Products and Nanotechnological Applications is the second of three volumes presenting detailed information on drug discovery against COVID-19. Part one of this volume presents chapters that focus on the various antiviral agents from natural products with the propensity to be used as chemical scaffolds for the development of drugs against COVID-19. Also captured is the dietary sources of antioxidant bioactives that could help boost the immune system for the management of COVID-19. Chapters in part two describe the application of nanotechnology for efficient and effective delivery of drugs against COVID-19. Written by global team of experts, this book is an excellent resource for drug developers, medicinal chemists, pharmaceutical companies in R&D and research institutes in both academia and industry. Presents the various antiviral bioactive compounds from natural products Discusses the roles of antioxidant in the prevention and management of COVID-19 Details the application of nanotechnology for efficient and effective drug delivery INDICE: PART I: ANTIVIRAL AGENTS FROM NATURAL PRODUCTS 1. COVID-19 management and phytomedicine interventions: Potentials and safety considerations 2. Plants with potent antiviral properties 3. Antiviral effects of medicinal plants and their active phytochemical constituents against respiratory diseases and associated biological functions 4. Herbs and drugs in clinical trials for coronavirus treatments 5. Herbal-Based Resources against Exanthematous Viral Infections and Other Viral Diseases 6. Dietary polyphenols as therapeutic agents to combat COVID-19 7. Bioactive compounds and herbal preparations implicated in for the treatment of SARS-CoV-2 8. Roles of Antioxidants in the Prevention and Management of Coronavirus Disease 2019 9. Food sources of natural antioxidants for body defence against SARS-CoV-2 10. Nutritional Management against Severe Acute Respiratory Syndrome Coronavirus-2 Infection

• ISBN: 978-0-323-95574-4
• Editorial: Elsevier
• Encuadernacion: Rústica
• Páginas: 378
• Fecha Publicación: 01/07/2022
• Nº Volúmenes: 1
• Idioma: Inglés